BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7809809)

  • 1. Interleukin-6 and coagulation-fibrinolysis fluctuations after laparoscopic and conventional cholecystectomy.
    Vander Velpen G; Penninckx F; Kerremans R; Van Damme J; Arnout J
    Surg Endosc; 1994 Oct; 8(10):1216-20. PubMed ID: 7809809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of coagulation and fibrinolysis in open and laparoscopic cholecystectomy.
    Dexter SP; Griffith JP; Grant PJ; McMahon MJ
    Surg Endosc; 1996 Nov; 10(11):1069-74. PubMed ID: 8881054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy.
    Schietroma M; Carlei F; Mownah A; Franchi L; Mazzotta C; Sozio A; Amicucci G
    Surg Endosc; 2004 Jul; 18(7):1090-6. PubMed ID: 15136925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in blood coagulation, fibrinolysis and cytokine profile during laparoscopic and open cholecystectomy].
    Schietroma M; Giuliani A; Agnifili A; Lely L; Carlei F; Pescosolido A; Amicucci G
    Chir Ital; 2008; 60(2):179-88. PubMed ID: 18689165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic activity in laparoscopic cholecystectomy.
    Martinez-Ramos C; Lopez-Pastor A; Núñez-Peña JR; Ruiz-Caravaca ML; Ruiz de Gopegui M; Sanz-López R; Jorgensen TW; Tamames-Escobar S
    J Laparoendosc Adv Surg Tech A; 1998 Dec; 8(6):417-23. PubMed ID: 9916595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolysis activation after single-incision versus standard laparoscopic cholecystectomy: a single-center prospective case-controlled pilot study.
    Zezos P; Christoforidou A; Kouklakis G; Tsalikidis C; Dimakis C; Laftsidis P; Virgiliou A; Simopoulos C; Pitiakoudis M
    Surg Innov; 2014 Feb; 21(1):22-31. PubMed ID: 23575915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation and fibrinolysis during laparoscopic cholecystectomy.
    Rahr HB; Fabrin K; Larsen JF; Thorlacius-Ussing O
    Thromb Res; 1999 Feb; 93(3):121-7. PubMed ID: 10030828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic responses of human peritoneal fluid in laparoscopic cholecystectomy: a prospective clinical study.
    Tarhan OR; Barut I; Akdeniz Y; Sutcu R; Cerci C; Bulbul M
    Surg Endosc; 2008 Apr; 22(4):1008-13. PubMed ID: 17763904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
    Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG
    Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
    Biemond BJ; Levi M; Ten Cate H; Van der Poll T; Büller HR; Hack CE; Ten Cate JW
    Clin Sci (Lond); 1995 May; 88(5):587-94. PubMed ID: 7614818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men.
    Kapiotis S; Jilma B; Szalay T; Dirnberger E; Wagner O; Eichler HG; Speiser W
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2861-7. PubMed ID: 9409267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.